These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 31785619)

  • 1. Role of the microbiome in occurrence, development and treatment of pancreatic cancer.
    Wang Y; Yang G; You L; Yang J; Feng M; Qiu J; Zhao F; Liu Y; Cao Z; Zheng L; Zhang T; Zhao Y
    Mol Cancer; 2019 Dec; 18(1):173. PubMed ID: 31785619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut.
    Yu Q; Jobin C; Thomas RM
    Neoplasia; 2021 Feb; 23(2):246-256. PubMed ID: 33418277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiomes in pancreatic cancer can be an accomplice or a weapon.
    Guo X; Wang P; Li Y; Chang Y; Wang X
    Crit Rev Oncol Hematol; 2024 Feb; 194():104262. PubMed ID: 38199428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer.
    Kemp SB; Pasca di Magliano M; Crawford HC
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1531-1542. PubMed ID: 34303882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Microbiome in Pancreatic Cancer-Implications for Diagnosis and Precision Bacteriophage Therapy for This Low Survival Disease.
    Kabwe M; Dashper S; Tucci J
    Front Cell Infect Microbiol; 2022; 12():871293. PubMed ID: 35663462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiome and Pancreatic Cancer Development and Treatment.
    Attebury H; Daley D
    Cancer J; 2023 Mar-Apr 01; 29(2):49-56. PubMed ID: 36957973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Insights Into the Biology and Treatment of Pancreatic Cancer.
    Mettu NB; Abbruzzese JL
    J Oncol Pract; 2016 Jan; 12(1):17-23. PubMed ID: 26759461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary.
    Stoffel EM; McKernin SE; Khorana AA
    J Oncol Pract; 2019 Feb; 15(2):108-111. PubMed ID: 30589608
    [No Abstract]   [Full Text] [Related]  

  • 9. Research progress on circularRNAs in pancreatic cancer: emerging but promising.
    Wang YZ; An Y; Li BQ; Lu J; Guo JC
    Cancer Biol Ther; 2019; 20(9):1163-1171. PubMed ID: 31138014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients.
    Sammallahti H; Kokkola A; Rezasoltani S; Ghanbari R; Asadzadeh Aghdaei H; Knuutila S; Puolakkainen P; Sarhadi VK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment.
    Zhao Z; Liu W
    Technol Cancer Res Treat; 2020; 19():1533033820962117. PubMed ID: 33357065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of caveolin-1 regulators in pancreatic cancer.
    Chen T; Liu L; Xu HX; Wang WQ; Wu CT; Yao WT; Yu XJ
    Asian Pac J Cancer Prev; 2013; 14(8):4501-7. PubMed ID: 24083692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment.
    Gao F; Yu B; Rao B; Sun Y; Yu J; Wang D; Cui G; Ren Z
    Front Immunol; 2022; 13():1051987. PubMed ID: 36466871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connecting the Human Microbiome and Pancreatic Cancer.
    Sexton RE; Uddin MH; Bannoura S; Khan HY; Mzannar Y; Li Y; Aboukameel A; Al-Hallak MN; Al-Share B; Mohamed A; Nagasaka M; El-Rayes B; Azmi AS
    Cancer Metastasis Rev; 2022 Jun; 41(2):317-331. PubMed ID: 35366155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome as a biomarker and therapeutic target in pancreatic cancer.
    Pourali G; Kazemi D; Chadeganipour AS; Arastonejad M; Kashani SN; Pourali R; Maftooh M; Akbarzade H; Fiuji H; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Khazaei M; Avan A
    BMC Microbiol; 2024 Jan; 24(1):16. PubMed ID: 38183010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining and Treating Borderline Resectable Pancreatic Cancer.
    Perri G; Prakash L; Katz MHG
    Curr Treat Options Oncol; 2020 Jul; 21(9):71. PubMed ID: 32725270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications.
    Amara S; Yang LV; Tiriveedhi V; Muzaffar M
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Dclk1 in the pathogenesis, diagnosis, prognosis and treatment of pancreatic cancer: A review.
    Wang Y; Yi J; Liu X
    Expert Rev Gastroenterol Hepatol; 2022 Jan; 16(1):13-19. PubMed ID: 34937474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.